A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

Lung Cancer

Volumn 50, Issue 1, 2005, Pages 91-96

  Scagliotti, Giorgio V ^a   Smit, Egbert ^b   Bosquee, Lionel ^c   O'Brien, Mary ^d   Ardizzoni, Andrea ^e,l   Zatloukal, Peter ^f   Eberhardt, Wilfried ^g   Smid Geirnaerdt, Maartje ^h   De Bruin, Hein G ⁱ   Dussenne, Sonia ^j   Legrand, Catherine ^j   Giaccone, Giuseppe ^k  

^a Department of Clinical and Biological Sciences   (Italy)

^b MARTINI HOSPITAL   (Netherlands)

^c Centre Hospitalier Regional de La Citadelle   (Belgium)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h Stichting Oosterschelde Ziekenhuizen   (Netherlands)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j EORTC DATA CENTER   (Belgium)

^k VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^l University Hospital Parma   (Italy)

more..

Author keywords

Chemotherapy; Non small cell lung cancer; Paclitaxel; Taxanes

Indexed keywords

CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; RANITIDINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; DEATH; DISEASE COURSE; DRUG FATALITY; DRUG RESPONSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEADACHE; HEART ARRHYTHMIA; HUMAN; INFECTION; LETHARGY; LEUKOPENIA; LUNG ALVEOLUS CELL CARCINOMA; LUNG SURGERY; LUNG TOXICITY; MALAISE; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MYALGIA; NAUSEA AND VOMITING; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24744464361     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.05.012     Document Type: Article

References (21)

1. R.J. Ginsberg, M.K. Kris, and J.G. Armstrong Cancer of the lung V.T. DeVita Jr. S. Hellman S.A. Rosemberg Cancer. Principle and practice of oncology 4th ed. 1993 J.B. Lippincott Company Philadelphia 673 723
2. J.E. Barkley, and M.R. Green Bronchioloalveolar carcinoma J Clin Oncol 14 1996 2377 2386
3. A. Morabia, and E.L. Wynder Relation of bronchioloalveolar carcinoma to tobacco BMJ 304 1992 541 543
4. W.L. Read, N.C. Page, R.M. Tierney, J.F. Piccirillo, and R. Govindan The epidemiology of bronchioloalveolar carcinoma Proc. Am. Soc. Clin. Oncol. 21 2002 317a Abstract 1267
5. R.C. Daly, V.F. Trastek, P.C. Pairolero, P.A. Murtaugh, M.S. Huang, and M.S. Allen Bronchoalveolar carcinoma: factors affecting survival Ann. Thorac. Surg. 51 1991 368 377
6. K. Okubo, E.J. Mark, D. Flieder, J.C. Wain, C.D. Wright, and A.C. Moncure Bronchoalveolar carcinoma: clinical, radiologic and pathologic factors and survival J. Thorac. Cardiovasc. Surg. 118 1999 702 709
7. S.H. Barsky, R. Cameron, K.E. Osann, D. Tomita, and E.C. Holmes Rising incidence of bronchioloalveolar lung carcinoma and its clinicopathological features Cancer 73 1994 1163 1170
8. C.F. Mountain Revision in the international system for staging lung cancer Chest 111 1997 1710 1717
9. World Health Organization Handbook for reporting results of cancer treatment. Publication 48 1979 WHO Geneva (Switzerland)
10. http://ctep.info.nih.gov/reporting/ctc.html.
11. G. Clayton Bronchioloalveolar carcinomas cells type, patterns of growth, and prognostic correlates Cancer 57 1986 1555 1564
12. J.B. Sørensen, F.R. Hirsch, A. Gazdar, and J.E. Olsen Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma Cancer 71 1993 2971 2976
13. C.Y. Castro, D.M. Coffey, L.J. Medeiros, and P.T. Cagle Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung Ann. Diagn. Pathol. 5 5 2001 274 284
14. M. Ebright, M. Zakowski, J. Martin, E.S. Venkatraman, V.A. Miller, and M.S. Bains Clinical pattern and pathological stage but not histological features predict outcomes for bronchioloalveolar carcinoma (BAC) Ann. Thorac. Surg. 74 2002 1640 1646
15. M. Ranson, N. Davidson, M. Nicholson, S. Falk, J. Carmichael, and P. Lopez Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small cell lung cancer J. Natl. Cancer Inst. 92 2000 1074 1080
16. P.B. Vance, J.C. Crowley, R.B. Livingston, and D.R. Gandara A phase II Southwest Oncology Group trial (S9714) utilizing paclitaxel by 96-h infusion in stage IIIb and IV bronchioloalveolar carcinoma of the lung (BAC) Proc. Am. Soc. Clin. Oncol. 20 2001 336 Abstract 1340
17. V.A. Miller, M.G. Kris, N. Shah, J. Patel, J. Patel, C. Azzoli, and J. Gomez Bronchioloalvealar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small cell lung cancer J. Clin. Oncol. 22 2004 1103 1109
18. H.L. West, W.A. Franklin, P. Gumerlock, R.B. Vance, D.H.M. Lau, and K. Chansky ZD1839 (Iressa) in advanced bronchioloalveolar carcinoma (BAC): a preliminary report of SWOG S0126 Lung Cancer 41 Suppl. 2 2003 S56 Abstract O-187
19. J.D. Patel, V.A. Miller, M.G. Kris, N. Shah, B. Pizzo, and L. Tyson Encouraging activity and durable responses demonstrated by the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) shows in patients with advanced bronchioloalveolar cell carcinoma (BAC) Lung Cancer 41 Suppl. 2 2003 S56 Abstract O-188
20. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, and B.W. Brannigan Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
21. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, and S. Gabriel EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500